Endeavor

New Combination Treatment May Help Slow Advanced Melanoma

Adding HBI-8000 to nivolumab delayed melanoma progression in a phase 3 trial

Moffitt Trial Reports Higher Survival for HER2-Positive Breast Cancer Patients With Leptomeningeal Metastases

The phase 2 trial shows patients treated with radiation therapy followed by two antibodies delivered intrathecally had a median overall survival of 36 months

Personalized Melanoma Vaccine Shows 42% Reduction in Recurrence, Death Risk

New phase 3 findings build on earlier research and offer new hope for patients with high-risk melanoma following surgery

New Initiative Hopes To Bring Clinical Trials to Breast Cancer Patients in Barbados

Women on the Caribbean island are more likely to be diagnosed with an aggressive form of the disease

Cell Therapy Changed Cancer Care. Now Researchers Want to Make It Work Better

Moffitt brought together experts from across the country to explore ways to make cell therapies more durable and effective for more patients

5 Questions About Metastatic Breast Cancer

Moffitt Cancer Center expert explains what you need to know

Moffitt Trial Tests Immunotherapy Without Chemotherapy for Early Stage Breast Cancer

Florida mother had a complete response to dendritic cell vaccines prior to surgery

From Finish Lines to Infusion Chairs: One Athlete's Journey Through Rare Cancer

After a mantle cell lymphoma diagnosis, Jose Beltran sought a second opinion and found a new path through an immunotherapy clinical trial

Study Explores Immunotherapy Combination for Metastatic Cervical Cancer

Moffitt researchers found that combining radiation and immunotherapy may benefit patients with advanced disease